Scilex Holding Company's subsidiaries, ACEA Therapeutics and ACEA Pharma, have agreed to sell 100% of ACEA Pharma to Phoenix Asia Holdings for $1 billion in newly issued Phoenix shares. Following the acquisition, Phoenix will be renamed ACEA Pharma, Inc. and is expected to be listed on Nasdaq. The deal, approved by all boards, is expected to close by the end of Q2 2026, with ACEA Therapeutics owning about 82% of the new company. This move aims to strengthen the combined company's market presence and accelerate growth in non-opioid pain management and other therapeutic areas.
EQT Corporation is expected to report Q2 2026 earnings per share of $0.41 and revenue between $1.79 billion and $1.84 billion. The forecast is pressured by weaker natural gas prices and a negative Earnings ESP of -10%, indicating a risk of missing co...
Zoom Video Communications has appointed Carlos Quaderi as Head of Asia Pacific (APAC), effective August 1, 2026. Quaderi will oversee Zoom's go-to-market strategy across APAC, including Australia, New Zealand, Asia, India, and Korea (excluding Japan)...
Domino's Pizza reported a Q2 earnings per share (EPS) of $4.07, slightly below the expected $4.11, reflecting slower US sales growth and weaker customer spending. The company faces pressure as pizza sales lag behind other fast-food categories, partly...
Home Bancorp reported earnings per share of $1.49, surpassing the $1.46 estimate, and revenue of $45.48 million, well above the $38.57 million forecast. This marks the fourth consecutive quarter of revenue growth exceeding expectations. The bank show...
FDH Aero and LATECOERE have entered a global supply agreement, making FDH Hardware a key supplier for LATECOERE's manufacturing sites in Brazil, Bulgaria, France, the Czech Republic, Tunisia, and Morocco. This partnership aligns FDH Aero's hardware p...
